Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - transcriptase
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Improved simian HIV (SHIV) prevention in non-human primate models with chemoprophylaxis combination that can be taken in one or two oral doses before or after exposure
HIV and AIDS remain persistent problems for the United States and countries around the world. In 2015, nearly 40,000 people were diagnosed with HIV in the US alone. Pre-exposure prophylaxis (PrEP) can help prevent HIV infections in people who are not infected with HIV but are at high risk of becoming infected with HIV. PrEP involves taking daily medications...
Published: 5/9/2025
|
Inventor(s):
Ivana Massud
,
Walid Heneine
,
Jose Garcia Lerma
Keywords(s):
Chemoprophylaxis
,
Combinations
,
Containing
,
HIV
,
Improved
,
Inhibitors
,
Integrase
,
NCHHSTP
,
NCHHSTP-DHAP
,
Reverse
,
TRANSCRIPTASE
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
Pyrophosphate Analog HIV-1 Reverse
Transcriptase
Inhibitors
The invention relates to compounds that inhibit HIV-1 DNA synthesis mediated by reverse
transcriptase
(RT). HIV-1 DNA synthesis by RT utilizes deoxynucleoside 5’-triphosphate (dNTP) as substrate and like many other enzymes, the reaction is reversible. Pyrophosphate analogs like imidodiphosphate strongly promote reverse reaction dNTP products containing...
Published: 10/28/2024
|
Inventor(s):
William (Bill) Beard
,
David Shock
,
Samuel Wilson
Keywords(s):
DB4AXX
,
HIV-1
,
INHIBITING
,
PYROPHOSPHATE
,
TRANSCRIPTASE
,
VLXXXX
,
YBXXXX
Category(s):
Collaboration Sought > Collaboration
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease
High Level Expression and Purification of Untagged and Histidine-tagged Human Immunodeficiency Virus Type-1 Reverse
Transcriptase
Human immunodeficiency virus type-1 reverse
transcriptase
(HIV-1 RT) gene encodes 560 amino acids. In the virus, however, HIV-1 RT occurs as a dimer of two related polypeptides, p66 and p51 subunits at a molar ratio of 1:1. The p51 subunit is derived from a C-terminal proteolytic cleavage of the p66 subunit. This invention describes a simplified protocol...
Published: 10/28/2024
|
Inventor(s):
Rajendra Prasad
,
Ester Hou
,
Samuel Wilson
Keywords(s):
BBXXXX
,
DDXXXX
,
DEXXXX
,
DXXXXX
,
Expression
,
High
,
Histidine-tagged
,
Human
,
Hyper IgM syndrome
,
Immunodeficiency
,
Immunodeficiency 2
,
Immunodeficiency 4
,
Immunodeficiency-3
,
Level
,
purification
,
Reverse
,
Severe combined immunodeficiency, x-linked
,
TRANSCRIPTASE
,
TYPE-1
,
Untagged
,
virus
,
Wiskott Aldrich syndrome
Category(s):
Collaboration Sought > Licensing
,
Application > Research Materials
,
TherapeuticArea > Infectious Disease